Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
| Product: | ENHERTU |
| Active Ingredient: | Trastuzumab deruxtecan 100mg |
| Dosage Form: | Powder for concentrate for infusion |
| New Zealand Sponsor: | AstraZeneca Limited |
| Manufacturer: | Baxter Oncology GmbH, Halle-Kunsebeck Westfalen, Germany |
| Product: | Noradrenaline BNM |
| Active Ingredient: | Noradrenaline acid tartrate 2mg/mL |
| Dosage Form: | Concentrate for injection |
| New Zealand Sponsor: | Boucher & Muir (New Zealand) Limited t/a BNM Group |
| Manufacturer: | Sintetica SA, Mendrisio, Switzerland |
Dated this 12th day of August 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).